The Australian Pharmaceutical Manufacturers Association Code of Conduct: Guiding the promotion of prescription medicines

Australian Prescriber

Volumn 22, Issue 4, 1999, Pages 78-80

  Roughead, E E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Advertising; Pharmaceutical promotion; Regulation

Indexed keywords

AUSTRALIA; DRUG INFORMATION; DRUG MANUFACTURE; PHARMACEUTICAL CARE; POLICY; PRACTICE GUIDELINE; PRESCRIPTION; SHORT SURVEY;

EID: 0032821568     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.1999.067     Document Type: Short Survey

References (7)

1. Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med 1988;26:1183-9.
2. World Health Organization. Ethical criteria for medicinal drug promotion. Geneva:World Health Organization: 1988.
3. Australian Pharmaceutical Manufacturers Association. Code of Conduct annual report 1998. Sydney:Australian Pharmaceutical Manufacturers Association; 1998.
4. Langman M. The code for promoting drugs. Br Med J 1988;297:499-500.
5. Herxheimer A. Collier J. Promotion by the British pharmaceutical industry. 1983-8: a critical analysis of self-regulation. Br Med J 1990;300:307-11.
6. Carandang ED, Moulds RF. Pharmaceutical advertisements in Australian medical publications - have they improved? Med J Aust 1994;161:671-2.
7. Roughead EE, Gilbert AL, Harvey KJ. Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives presentations to general medical practitioners? Intern J Health Services 1998;28:269-79.